This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Expanding the potential patient population for pulsed field ablation, results from the SINGLE SHOT CHAMPION study suggest PFA might be just as good as cryoballoon ablation for patients with paroxysmal AFib. Atrial tachyarrhythmia recurred in 37.1% The post PFA or Cryoballoon for Paroxysmal AFib?
Atrialfibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heart failure, making it essential to understand its causes, symptoms, and AFib treatment options. What is AtrialFibrillation?
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.
18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrialfibrillation (AFib) who are at an increased risk of stroke. tim.hodson Tue, 11/19/2024 - 15:57 Nov. 16-18, 2024).
Atrialfibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrialfibrillation (AFib) recurrence.
Patients who undergo catheter ablation for atrialfibrillation (AFib) who also have heart failure with preserved ejection fraction (HFpEF) experienced a greater benefit from ablation in terms of clinical outcome, AFib recurrence and functional status, according to findings from the CABANA trial.
Using a wearable device, such as a smart watch, to track health data and symptoms, is supposed to help people monitor their health and address symptoms as quickly as possible to spur positive health outcomes.
(MedPage Today) -- For patients undergoing catheter ablation for atrialfibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.
Additional rhythm-control strategies are frequently continued after index ablation for atrialfibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre. Oguzhan Ekrem Turan. COMING AHEAD: www.adncoe.com
EGF mapping allows physicians to detect EGF sources and is designed to individualize ablation strategies based on underlying pathophysiologic mechanisms to potentially improve outcomes. AFib is the most common heart rhythm disorder, affecting more than 30 million patients worldwide.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
History of prior heart failure (HF) was found to influence prognostic implications of atrialfibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as presenting rhythm differentiating outcome.
It is with great pride that we announce the resounding success of ADN CoE' s AFib Ablation Training program, the second installment in our esteemed Ablation Series, held at the prestigious 9 Eylül University Heart Rhythm Management Centre. Oguzhan Ekrem Turan. COMING AHEAD: www.adncoe.com
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4
(MedPage Today) -- LONDON -- For patients with atrialfibrillation (Afib) and stable coronary artery disease (CAD), edoxaban (Savaysa) monotherapy improved net outcomes weighing together bleeding and ischemic events as compared with dual antithrombotic.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
The decision to perform catheter ablation for atrialfibrillation (AF) is often driven by symptom severity. However, ablation outcomes in asymptomatic patients compared to symptomatic patients remain underexplored.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. If you or someone you know is living with AFib, understanding the condition and how to prevent attacks is crucial. What Is AFib? How Do You Know If You Have AFib?
The association between hospital and physician procedure volume outcome has not been well evaluated for atrialfibrillation (AF) ablation in contemporary practice.
Patients undergoing atrialfibrillation (AFib) ablation who were not properly anticoagulated and did not undergo preprocedural transesophageal echocardiogram (TEE) were significantly more likely to suffer from transient ischemic attack (TIA) or pulmonary embolism (PE).
Pulmonary embolism (PE) and atrialfibrillation (AFib) frequently coexist, with AFib increasing the risk of thromboembolic events such as PE. The combination of these conditions is associated with worse clinical outcomes, higher mortality, and increased healthcare burden.
Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrialfibrillation (NVAF) treatment. Stroke is a major concern for millions of people living with atrialfibrillation, and as physicians, we strive to deliver better outcomes for these patients."
The transeptal puncture (TSP) is a necessary step during catheter ablation (CA) for atrialfibrillation (AF). There is no consensus regarding the need for a single or double TSP left atrial access for CA of AF.
PMH: Known paroxysmal Atrial fib. He is usually is in sinus rhythm as far as he knows, but he cannot subjectively feel atrialfibrillation, so he is never completely certain when he is in sinus or atrial fib. Here is his ECG: Atrial Fib with a Ventricular Response of about 66. He immediately completely recovered.
Obstructive sleep apnea (OSA) and atrialfibrillation (AF) are highly prevalent, often coexisting conditions. Untreated OSA causes negative cardiac remodeling and can worsen AFiboutcomes. Despite guideline recommendations to address OSA as part of AF management, OSA screening practices are sub-optimal.
Abstract Introduction Atrialfibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
In this weeks View, Dr. Eagle looks at arrhythmia recurrence and rhythm control after catheter ablation for atrialfibrillation. He then discusses long-term outcomes in transthyretin amyloid cardiomyopathy in patients treated with tafamidis.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention. These early warnings are critical, as AFib increases the risk of stroke and other heart-related complications.
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. The expo floor was a veritable candy store for the scientifically minded electrophysiologist, with displays of wares that promised to improve the clinician’s outcomes.
Preprocedural transesophageal echocardiogram (TEE) has been a routine component of atrialfibrillation (AF) ablation procedures since the origin of this procedure. However, practice changes regarding preprocedural imaging and anticoagulation management have reduced the necessity of pre-ablation TEE.
Catheter ablation (CA) for atrialfibrillation (AF) and heart failure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes. The patient characteristics, AF effect on quality-of-life questionnaire (AFEQT), and ablation strategies performed remains uncertain in those with and without HFrEF.
Catheter ablation for atrialfibrillation (AF) is an effective rhythm control strategy. However, there is limited evidence on long-term clinical benefits and safety for asymptomatic patients. Evaluating these is crucial to inform clinical decision-making and improve patient selection.
However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. years and were more likely to be males (62%), diabetic (41% vs 35%, p=0.046), and have a higher prevalence of atrialfibrillation (Afib) (53% vs 39%, p<0.001).
About a million possible cases of atrialfibrillation, a known risk for stroke, go undetected in Japan. The AI lineup currently covers both continuous ECG tracking and AFib detection. You are currently developing a new AI to detect AFib. A local startup is introducing an innovative AI targeting this growing danger.
By understanding the nuances of abnormalities detected in Cardiomatics and interpreting detailed reports, healthcare professionals can intervene promptly to prevent adverse outcomes. AFIB/AFL – atrialfibrillation or atrial flutter episodes. AV blocks – 2nd degree and 3rd degree atrioventricular blocks.
Atrialfibrillation is also a predictor of worse outcomes in this case (Alborzi). Other Arrhythmias ( PACs, PVCs, AFib, Bradycardia and AV conduction disorders — potentially lethal VT/VFib ). RBBB in blunt chest trauma seems to be indicative of several RV injury. Sinus Tachycardia ( common in any trauma patient. ).
OSA is commonly seen in patients with arrhythmias like atrialfibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY. billion (2).
cardiac electrophysiologist, performed one of the nations first procedures to control atrialfibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.
"Based on the results from the admIRE clinical trial, we are confident that this innovation has the promise to deliver significant value and differentiated capabilities, and become an important tool for the treatment of AFib." 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. In the U.S.,
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. 1 Approximately 33 million patients worldwide are living with AFib.
Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrialfibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting. The patient was placed on telemetry.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content